LegoChem Biosciences and Iksuda Therapeutics expand License Agreement for development of antibody-drug conjugates

By | June 22, 2021
Iksuda Therapeutics today announced that it has expanded its research collaboration and License Agreement with LegoChem Biosciences, Inc.